We assessed the accuracy of C-reactive protein (CRP) levels and lymphocyte counts to predict a mechanical complication (MC) after myocardial infarction (MI). Within 10 years, we identified 36 patients with 39 echocardiographically confirmed MC within 30 days of MI: ventricular septal defect (17 cases), papillary muscle rupture (10 cases), and left ventricular free wall rupture (12 cases). They were compared to 41 controls with an uncomplicated hospital course after MI. Peak CRP levels and minimum relative lymphocyte counts obtained within 96 h of the acute MI (AMI) and before diagnosis of the complication were compared with clinical parameters. Prior to the MC, peak CRP levels were significantly higher (p ! 0.001) and relative lymphocyte counts lower (p ! 0.001) than in controls while creatine kinase levels did not differ (p = nonsignificant). Using multivariate logistic regression, the following score was identified to have excellent prognostic significance for MC: CRP (mg/l) -10 ! Lyc (%). The area under the receiver-operating characteristic curve was 0.90 B 0.05 (p ! 0.001). Combined use of CRP levels and relative lymphocyte counts may be helpful in accurately predicting an MC after AMI and should therefore be routinely assessed.
Introduction
Mechanical complications (MC) after acute myocardial infarction (AMI) include papillary muscle rupture (PMR) with severe mitral regurgitation, ventricular septal rupture with a ventricular septal defect (VSD) and freewall rupture (FWR). Although infrequently occurring (affecting 2-3% of patients with AMI [1] ), the poor prognosis of an MC if left uncorrected demands early diagnosis based on a high degree of suspicion. Previous reports have focused mainly on clinical and pathological risk factors for MC [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Known risk factors include advanced age, female gender, a first, anterior or transmural myocardial infarction (MI), and no history of previous smoking [3, 6, 7, 11] . Furthermore, ST-segment elevation in lead aVL on the admission ECG, abrupt hypotension or bradycardia have been described to be related to MC [12] . Still, the predictive value of these features to identify patients likely to sustain an MC is limited.
The prognostic significance of laboratory tests such as raised serum levels of the acute-phase reactant C-reactive protein (CRP) after an AMI has rarely been examined [8, 11] . A raised CRP level has been described as a predictor of FWR [8, 11] . However, the prognostic relevance of elevated CRP levels for other MC has never been explored. Another potentially useful marker of an MC after AMI may be relative lymphocytopenia (defined as a percentage of lymphocytes !20% of all white blood cells, WBC [13] ), reflecting a stressful state with increased cortisol release correlating with infarct size [10, 14] .
We tested the hypothesis that combined use of both markers, elevated CRP and relative lymphocytopenia, enables an accurate prediction of MC after AMI. For this purpose, we retrospectively compared clinical and laboratory data of patients with an echocardiographically proven MC after AMI to patients with an uncomplicated hospital course (controls).
Patients and Methods

Patients
We reviewed the charts of all 69 consecutive patients admitted to our department between January 1990 and October 2000 suffering an MC within 30 days of an AMI. MC were defined as echocardiographically confirmed VSD, PMR or FWR located within the infarcted region. We included only those 36 patients with 39 MC who had full documentation of CRP levels and relative lymphocyte counts within the first 96 h after AMI. Baseline characteristics of the patients with incomplete data did not differ from those included in the study (data not shown).
The control group comprised patients admitted during 1 year (1996) and consisted of all consecutive AMI patients without an MC and with an uncomplicated hospital course (no signs of severe heart failure, infection, bleeding needing blood transfusions, or other serious disorders affecting study results) and full documentation of CRP levels and lymphocyte counts. There were 41 control patients who fulfilled these inclusion criteria.
Study Protocol
We collected the following data: age, gender, coronary risk factors (smoking, hypertension, body mass index 1 30 kg/m 2 , family history of coronary artery disease, CAD, diabetes mellitus or hyperlipidemia), a history of CAD or previous MI, number of coronary arteries affected by CAD (650% stenosis of major epicardial coronary artery) and previous coronary artery bypass grafting.
Furthermore, we obtained the following information: infarct localization (classified as anterior or non-anterior), infarct size (according to the peak levels of creatine phosphokinase), transmural AMI (new Q waves on ECG), infarct-related artery (verified by coronary angiography), percutaneous coronary intervention, medication between MI and cardiac rupture (aspirin, ß-blockers, thrombolytic therapy, angiotensin-converting enzyme inhibitors or heparin), serum CRP levels and relative lymphocyte counts.
Laboratory Data
To obtain peak CRP levels and the nadir of relative lymphocyte counts, all available data from the advent of AMI and the subsequent first 96 h or until the diagnosis of the MC (if it occurred earlier) were used (measured at least every 48 h). In the control group, we used all available data from the first 96 h after the AMI. CRP levels were measured by a turbidimetric assay (Wako CRP HR II) with the use of an automatic analysis system (Hitachi 747). The leukocyte differential analysis was performed with the use of an automated hematology analyzer (Technicon, Bayer Diagnostics).
Statistical Analysis
Values are expressed as means B SD or percent. Characteristics were compared between the two groups using the ¯² test, Fisher's exact test, the independent-samples t test or the Mann-Whitney U test, as appropriate. Mean values of CRP levels and lymphocyte counts were compared between controls and patients with VSD, PMR, and FWR, respectively, using one-way analysis of variance. Spearman's rank correlation was used to test the relationship between CRP levels and relative lymphocyte counts. Logistic regression analysis was used to test whether parameters are related to MC and to calculate odds ratios. After performing univariate analysis, multivariate logistic regression was used to test independency of each parameter found to be significantly related to MC. Bivariate logistic regression analysis was used to calculate a score, considering both CRP levels and lymphocyte counts. The area under the receiver-operating characteristic (ROC) curve, computed by a modification of the Wilcoxon statistics, as proposed by Hanley and McNeil [15] , was used to determine the discriminatory power of various CRP levels, lymphocyte counts and the combined score to predict an MC after AMI. A p value ^0.05 was considered to show a statistically significant difference. Analyses were performed using the statistical package SPSS for Windows 9.0.
Results
Of the 39 mechanical complications, 17 (43%) were VSD, 12 (31%) FWR, and 10 (26%) PMR occurring 105 B 96 h after the AMI. Table 1 compares the clinical data of patients with and without an MC. Patients with MC tended to be older and showed a male predominance. A history of CAD and MI as well as a history of hyperlipidemia and smoking were less common in patients with MC. The higher incidence of previous coronary bypass grafting in patients without a rupture was not statistically significant.
The characteristics of AMI are shown in table 2. The incidence of transmural infarction and non-anterior AMI was higher in patients with MC than in those without. Single-vessel disease was less common in the control group. There was a higher percentage of patients treated with ß-blockers and heparin in the group without rupture, whereas no significant difference was detected in other medications. Percutaneous coronary interventions were more common in control patients. There was no significant difference in peak CK levels. In patients undergoing coronary angiography, no significant difference could be detected in the infarct-related artery. As shown in table 2, there were significant differences in peak CRP levels and relative lymphocyte counts, respectively, comparing patients with and without MC. In table 3, CRP levels and lymphocyte counts were compared between control patients and the three different MC. FWR resulted in the highest CRP levels, followed by PMR and VSD. Relative lymphocyte counts were lowest in patients with PMR. However, all the differences between the different complications were not statistically significant.
Odds ratios of CRP levels and relative lymphocyte counts for the detection of MC are shown in table 4. Various variables were related to the risk of MC. Of these, elevated CRP levels and relative lymphopenia obtained prior to the MC were among the most significant predictors. Figure 1 shows the ROC curves of the CRP levels and the lymphocyte counts, indicating the predictive value of the two parameters. A CRP level of 60 mg/l, for example, has a sensitivity of 79% and a specificity of 78%; a relative lymphocyte count of 11% has a sensitivity of 75% with a specificity of 75%. The coefficients of bivariate logistic regression led to a score using the following formula:
where CRP is the CRP level (in mg/dl) and Lyc equals the fraction of lymphocytes of the WBC count expressed in percent. Low scores indicate a low risk of MC. Figure 2 depicts the ROC curve of this score to detect an MC. The area under the curve of 0.90 indicates the high predictive value of this score. As a cutoff value, 50 could be identified, which seemed to be ideal with high sensitivity (i.e. 90%) and acceptable specificity (i.e. 83%).
Despite a significant correlation between CRP levels and relative lymphocyte counts (r = -0.40, p ! 0.001), multivariate logistic regression analysis revealed CRP levels and lymphocyte counts as independent predictors of prognosis. The only other independent predictor of MC was the use of ß-blockade.
Discussion
One key to successful treatment of an MC after AMI is the identification of those patients at greatest risk, enabling early diagnosis and adequate treatment [12, [16] [17] [18] [19] . Our study shows that early identification of an MC may be improved using a new simple score with peak CRP levels and the nadir of the percentage of lymphocytes which precede the MC. This score correctly identified the majority of patients suffering MC with an acceptable specificity.
Clinical and Pathologic Risk Factors for Cardiac Rupture
Our results confirmed previous findings that patients with an MC are older and more likely to have a transmural infarction, less severe degrees of CAD (single-vessel disease or no CAD) and no previous MI [2-4, 6, 7, 11] . Furthermore, in agreement with earlier studies, we found that rupture occurs less frequently in patients treated with ß-blockers immediately after the AMI [20] . This may be of clinical importance since the consequent use of early ß-blockade seems to be the most effectual measure of preventing MC after AMI. This may be one of the reasons for the reduction in clinical events by ß-blockade after AMI. There is, however, controversy regarding the site of infarction leading to rupture [1, 2, 21] . The present study showed a significant prevalence of the inferoposterior location in patients with rupture, which may be in line with a recent publication [22] . This was especially due to an increased incidence of inferior or posterior infarctions leading to PMR or FWR compared to anterior MI.
While all patients of the control group had been admitted directly to our medical department, 89% of the patients of the group with MC were referrals from other hospitals where a percutaneous coronary intervention after the AMI was not available. Therefore, the higher frequency of percutaneous coronary interventions in patients of the control group should not be overestimated. Recent data seem to indicate that primary angioplasty may reduce the risk of myocardial rupture compared to thrombolysis for AMI (a 100% decrease in VSD) [23] .
No significant difference among the two groups could be established regarding the incidence of thrombolysis, previous coronary artery bypass grafting or the infarctrelated artery. This is probably due to the small number of patients since it is known from the GUSTO-I trial that the occurrence of VSD after AMI is less frequent in the thrombolytic area than it was before [24] .
C-Reactive Protein
CRP is an acute-phase protein and is produced in hepatocytes by the stimulation of various cytokines, including interleukin-6, tumor necrosis factor and interleukin-1, which are released from monocytes and macrophages activated by inflammation, as observed in AMI. It is presumed that a massive local cardiac inflammation causes severe tissue vulnerability due to proteolytic enzymes from polymorphonuclear leukocytes, and, thus, contributes to rupture [2, 11, 16] . Therefore, a strong increase in serum CRP level, reflecting a high degree of inflammation, was suggested to be used for the identification of postinfarct patients at high risk for rupture [8, 11] . The present study strongly supports this conclusion, suggesting an increase in CRP level after AMI as a marker for increased risk not only of free wall rupture but also of PMR and VSD.
It could be contradicted that the increase in the CRP level might not only be the result of the inflammation induced by the infarcted tissue, but also a consequence of an already progressing subacute rupture, causing inflammation through intramyocardial hemorrhage. Although this contention cannot be ruled out completely, the time course of CRP levels favors the assumption of an influence of the inflammation process on the occurrence of MC. Thus, the peak CRP level was earlier than the MC in most patients (data not shown). If peak CRP levels had been influenced by a subacute rupturing process, they would have had to persist or even increase until the clinical diagnosis of the rupture. Additionally, it is important to note that CRP levels are related to MC after AMI irrespectively of the underlying mechanism and, therefore, useful in the risk assessment of patients after AMI.
Relative Lymphocytopenia
It is known that the relative lymphocytopenia after AMI is caused by an increase in cortisol release which is induced by myocardial necrosis and depends on the size of necrotic tissue [25] . Therefore, a low relative lymphocyte count, based upon a high cortisol level, would refer to a large amount of necrotic tissue and possibly a correlation between the size of infarcted tissue and its risk to rupture. Thus, a relatively low lymphocyte count could be used as a poor prognostic marker in patients after AMI. The result of our study confirmed the high risk of MC in patients with a low relative lymphocyte level.
However, the correlation between the low relative lymphocyte level and the risk of rupture could not be explained solely by the size of the infarcted region, as our results, as well as those of others, showed no significant correlation between the size of infarct (assessed by peak creatine kinase levels) and the risk of its rupture. Further elements which induce a cortisol release seem to influence the complication rate of MC after an AMI. On the other hand, peak creatine kinase levels are not optimal to estimate infarct size and may be inferior to serum-time activity curves of creatine kinase or serial myoglobin measurements [26, 27] .
Risk Score and ROC Curves
The multivariate analysis clearly demonstrated that both maximum CRP levels and minimal relative lymphocyte counts were independent predictors of MC. Importantly, despite the significant negative correlation between them, both variables independently and additionally contributed to the identification of patients at risk for MC. Accordingly, the combination of both resulted in an even more powerful marker for MC after AMI than either of the two variables alone.
Study Limitations
The major limitation of this study is its retrospective design. Therefore, CRP levels and lymphocyte counts were not assessed daily in every patient, and consequently information on their exact time course or nadir are not available. However, measurement of CRP levels at our hospital have been part of the routine for 110 years due to a special interest of our hematologist. The control population has only been recruited during 1 year and is relatively small. However, these are consecutive patients with little variation and, therefore, we do not think that this would have significantly affected our data. In addition, 1996 is still representative as statins were not routinely administered in the acute infarct setting at that time. However, statins were significantly less often given in the group with MC than in the control population. However, we are doubtful -but cannot exclude -that statins would have influenced the results as the reduction in CRP levels by statin therapy is only very small, e.g. 0.2 mg/dl in the PRINCE trial [28] .
Patients with severe heart failure or a concomitant infection were excluded from the control group. This will affect the diagnostic accuracy of this score which is only as good as we describe it for patients with an otherwise uncomplicated hospital course.
Not all of our patients with an AMI and not all patients in the control group have had an echocardiographic examination, therefore, we cannot exclude that some patients had an asymptomatic MC, especially, an FWR.
Conclusions
Combined use of peak CRP level and the nadir of relative lymphocyte count (using a combined score) enables accurate prediction of an MC after an AMI and should be used routinely. Prospective data are needed to clearly define the diagnostic accuracy of the score found in our study population.
